Epidemiological | Average duration of Ng/Ct (months) | 6–18 | Refs 46–48. Also depends on level of STI treatment |
Average duration of ulcerative STI (months) | 2–12 |
Average duration between HIV and AIDS (months) | 84 | Refs 49–51 |
Percentage of males circumcised | 99% | Ref 19 |
Transmission probabilities | Probability of HIV transmission per sex act: Male to female: | 0.001–0.003 | Refs 30, 31, 52 |
Female to male: | 0.0006–0.0014 | |
Percentage decrease in female to male HIV transmission probability if circumcised | 0–58% | Ref 53 |
Probability of STI transmission per sex act: Ng/Ct: | 0.10–0.53 | Refs 32–34, 54–57 |
Ulcerative STI: | 0.1–0.5 |
Average Ng/Ct co-factor per sex act | 2–8 | Refs 4, 58 |
Average ulcerative STI co-factor per sex act | 3–13 |
Sexual transmission multiplicative co-factor during high viraemia phase (for 1.5 months) | 10–20 | Refs 59–61 |
Condom efficacy per sex act | 80–95% | Refs 62, 63 |
Population size and demographic inputs | Initial size of sexually active population | 310,000 | |
Life expectancy in years | 51 | Ref 64 |
Average number of years live in the area | 40 | Ref 65 |
Fixed sexual behaviour | Average frequency of partner change: Main sexual partners per 6 months | 0.01–0.10 | 0.01–0.05 | Refs 20, 23. No data for casual partners of females in Cotonou, so assumed to be same as males |
Casual sexual partners per 6 months | 1.6–2.2 |
Average frequency of sex acts in: main partnerships (per month) | 4–12 | Few data for Cotonou, so inputs given ranges similar to other African settings40 |
Casual partnerships (per month) | 2–5 |
Sex worker sexual behaviour | Average monthly frequency of clients per FSW | 52 (28–104) | Refs 16, 21 |
Average duration of sex work in months | 24–72 | Current FSWs have been sex workers for about 2 years16 |
Distribution of sexual activity | Population distribution with respect to level of sexual activity | No partners | 20% | 14% | Refs 20–23, 65 |
Just main partner | 49–55% | 84% |
Main and casual partner | 2–12% | 0.8% |
Client of FSW and FSW | 13–29% | 1.2% |
Condom use | Average consistency of condom use: main partnerships per sex act | 5–15% | Refs 16, 20, 23 |
FSWs with their clients last sex act: | Not reached | 60% | Ref 16 |
Reached | 81% |
Distribution of condom use of males and females with their casual partnerships. | None | 44–54% | 40–80% | Refs 20, 23, 65, 66 |
Some | remainder | remainder |
All | 21–29% | 1–11% |
STI treatment of FSWs at SIDA-2 clinic | Coverage of STI screening among FSW | 12–15% | 200–250 SWs reached every month16 (250/1900 = 13.2% per month) |
Sensitivity of modified syndromic management (SM) or POC test | Ng/Ct | 48% (SM), 50–80% (POC)† | Ref 8. Assume treat all GUD but those caused by HSV-2 are not cured |
GUD | 100% |
Specificity of modified syndromic management (SM) or POC test | Ng/Ct | 75% (SM), 95% (POC)* |
GUD | 100% |
Effectiveness of treatment regimen | Ng/Ct | 95% | Most STI cases treated effectively except those due to HSV-2.16 |
GUD | 35–56% |
Cost of POC test for Ng/Ct (2004 $US) | 1–4† | No test currently available |
STI treatment at public and private clinics | Percentage of STI cases that never have symptoms | 10–35% | 10–35% | 81% of clients with Ng/Ct and TV were asymptomatic.28 Health dimensions of sex and reproduction.67 |
Percentage of males and females with symptoms that attend the clinic per month | 46–51% (39% to private clinic) | 46% of males sought health services if had STI.29 When clients had STI, 12% went to public clinic and 39% to private clinic.28 Few data on females so assumed same as males |
Percentage of individuals with STI symptoms at clinic that don’t have an STI | 50–80% | 40–80% | Greater than 47% of men and 36% of women with symptoms had no STI at health clinic7 |
Sensitivity of syndromic algorithm | Ng/Ct | 92% | 87% | For individuals with Ng/Ct symptoms at public health.7 Assume all cases of GUD are treated. |
GUD | 100% | 100% |
Specificity of syndromic algorithm | Ng/Ct | 60.3% | 42% |
GUD | 100% | 100% |
Effectiveness of treatment regimen | Ng/Ct | 50–90% | Michel Alary personal communication: 90-95% of STDs treated correctly in SIDA-2 supported clinics and 50% otherwise. HSV-2 not curable |
GUD | | 20–56% |